National Institutional Frameworks And The Hybridization Of Entrepreneurial Business Models: The German And Uk Biotechnology Sectors
AbstractGiven what institutional scholars have described as an inhospitable institutional climate for entrepreneurial business, why has the German biotechnology industry suddenly taken off, while in the UK, where a ''correct'' institutional architecture exists, has the industry shown signs of stagnation? To explain these trends the article develops a firm-centered approach, recognizing that firms work with institutional frameworks - often with help from public policies - to create new business strategies. The argument is developed that such processes are associated with the ''hybridization'' of business strategies at the micro level, combined with the generation of new constellations of particular institutional frameworks within relatively stable national models.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Taylor & Francis Journals in its journal Industry and Innovation.
Volume (Year): 8 (2001)
Issue (Month): 1 ()
Contact details of provider:
Web page: http://www.tandfonline.com/CIAI20
You can help add them by filling out this form.
CitEc Project, subscribe to its RSS feed for this item.
- Lehrer, Mark & Nell, Phillip & Gärber, Lisa, 2009. "A national systems view of university entrepreneurialism: Inferences from comparison of the German and US experience," Research Policy, Elsevier, vol. 38(2), pages 268-280, March.
- Akkermans, Dirk & Castaldi, Carolina & Los, Bart, 2009. "Do 'liberal market economies' really innovate more radically than 'coordinated market economies'?: Hall and Soskice reconsidered," Research Policy, Elsevier, vol. 38(1), pages 181-191, February.
- Heneric, Oliver & Engel, Dirk & Champenois, Claire, 2004.
"The Birth of German Biotechnology Industry: Did Venture Capital run the Show?,"
ZEW Discussion Papers
04-09, ZEW - Zentrum für Europäische Wirtschaftsforschung / Center for European Economic Research.
- Dirk Engel & Claire Champenois & Oliver Heneric, 2004. "The Birth of German Biotechnology Industry – Did Venture Capital run the show?," RWI Discussion Papers 0016, Rheinisch-Westfälisches Institut für Wirtschaftsforschung.
- Gilsing, Victor & Nooteboom, Bart, 2006. "Exploration and exploitation in innovation systems: The case of pharmaceutical biotechnology," Research Policy, Elsevier, vol. 35(1), pages 1-23, February.
- Lehrer, Mark & Asakawa, Kazuhiro & Behnam, Michael, 2011. "Home base-compensating R&D: Indicators, public policy, and ramifications for multinational firms," Journal of International Management, Elsevier, vol. 17(1), pages 42-53, March.
- Gittelman, Michelle, 2006. "National institutions, public-private knowledge flows, and innovation performance: A comparative study of the biotechnology industry in the US and France," Research Policy, Elsevier, vol. 35(7), pages 1052-1068, September.
- Mark Lehrer, 2007. "Organizing knowledge spillovers when basic and applied research are interdependent: German biotechnology policy in historical perspective," The Journal of Technology Transfer, Springer, vol. 32(3), pages 277-296, June.
- Casper, Steven & Whitley, Richard, 2004. "Managing competences in entrepreneurial technology firms: a comparative institutional analysis of Germany, Sweden and the UK," Research Policy, Elsevier, vol. 33(1), pages 89-106, January.
- Müller, Christian, 2001. "The Biotechnology industry in Germany and Japan," Working Papers 11, Hamburg University of Technology (TUHH), Institute for Technology and Innovation Management.
- Swan, Jacky & Goussevskaia, Anna & Newell, Sue & Robertson, Maxine & Bresnen, Mike & Obembe, Ademola, 2007. "Modes of organizing biomedical innovation in the UK and US and the role of integrative and relational capabilities," Research Policy, Elsevier, vol. 36(4), pages 529-547, May.
- DiVito, Lori, 2012. "Institutional entrepreneurship in constructing alternative paths: A comparison of biotech hybrids," Research Policy, Elsevier, vol. 41(5), pages 884-896.
- Franco Malerba & Fabio Montobbio, 2004. "Structural Change in Innovative Activities in Four Leading Sectors. An Interpretation of the Stylized Facts," Revue économique, Presses de Sciences-Po, vol. 55(6), pages 1051-1070.
- Whitley, Richard, 2003. "Competition and pluralism in the public sciences: the impact of institutional frameworks on the organisation of academic science," Research Policy, Elsevier, vol. 32(6), pages 1015-1029, June.
- Casper, Steven & Matraves, Catherine, 2003. "Institutional frameworks and innovation in the German and UK pharmaceutical industry," Research Policy, Elsevier, vol. 32(10), pages 1865-1879, December.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Michael McNulty).
If references are entirely missing, you can add them using this form.